FDA Media Alert Detail

Drug Shortage

FDA Drug Shortage: Sodium Bicarbonate Injection

  • U.S. Food and Drug Administration
  • August 24, 2026
  • ID: shortage-sodium-bicarbonate-injection-hospira-inc-a-pfizer-company-0409-6637-14

Drug Shortage Details

Generic NameSodium Bicarbonate Injection
Manufacturer / CompanyHospira, Inc., a Pfizer Company
Therapeutic CategoryEndocrinology/Metabolism, Gastroenterology, Pediatric
Availability StatusUnavailable
Status (FDA list)Current
NDC Package Code0409-6637-14
Presentation & Dosage Form

Sodium Bicarbonate, Injection, 50 mEq/50 mL (8.4%, 1 mEq/mL) Syringes (NDC 0409-6637-14)

Manufacturer Contact Info

844-646-4398


Content syndicated from the U.S. Food and Drug Administration (FDA) Drug Shortages Database.